Your privacy is very important to us.When you visit our website,please agree to the use of all cookies.For more information about personal data processing,please go to Privacy Terms.

Unveiling Tianlong's Contribution to Spinal Muscular Atrophy SMN1 Research
Release Date 2023-11-22

At Tianlong, we are committed to advancing genetic testing and molecular diagnostics. In this article, we delve into the realm of spinal muscular atrophy SMN1. Join us as we explore how Tianlong is making strides in SMA research and diagnosis.

A3.jpeg

Understanding Spinal Muscular Atrophy and SMN1

Spinal Muscular Atrophy, abbreviated as SMA, is a genetic disorder that affects motor neurons in the spinal cord, leading to progressive muscle weakness, atrophy, and even paralysis. A key player in the SMA narrative is the Survival Motor Neuron 1 gene. Let's explore the significance of SMN1 in SMA and how Tianlong is contributing to this field.

 

The Role of SMN1 in SMA

The SMN1 gene is central to SMA, as it encodes a protein crucial for motor neuron survival. In SMA patients, mutations in SMN1 can result in a deficiency of this essential protein, leading to motor neuron degeneration and the associated symptoms. Early detection and precise analysis of SMN1 mutations are paramount for timely intervention and improved patient outcomes.

 

Tianlong's SMN1 Gene Detection Kit: Paving the Way for SMA Diagnosis

Here at Tianlong, we take pride in our cutting edge technology and commitment to genetic testing. Our Human Survival Motor Neuron 1 Gene Detection KitP124H is at the forefront of SMA diagnosis. With this kit, we offer a comprehensive solution for identifying SMN1 mutations and determining copy numbers in exon 7 and exon 8.

 

Our Quality Performance: Our kit excels in differentiating between 0, 1, and more than 2 copies of SMN1, allowing for the accurate identification of SMA carriers and patients.

Reduced Complexity: Tianlong Gentier96E/R automates data analysis, simplifying the process and ensuring precise results.

Optimized Workflow: With DNA-to-data results achievable in just 23 hours, including minimal hands-on time, we streamline SMA diagnosis for healthcare professionals.

Low Sample Concentration: Our kit can work with samples as low as 10 ng/μL, making it versatile and adaptable to various clinical scenarios.

High Precision: We take pride in the high precision of our kit, with a CV% of the R-value of less than 6%, ensuring reliable results.

 

Conclusion

In conclusion, Tianlong's dedication to advancing SMA research and diagnosis through our SMN1 Gene Detection KitP124H is unwavering. We understand the critical importance of early detection and accurate diagnosis in improving the lives of SMA patients.

With our state-of-the-art technology and commitment to quality, we aim to continue making a significant impact on SMA diagnosis and ultimately contribute to the wellbeing of individuals affected by this genetic disorder.


Share